EPISODE · Apr 25, 2026 · 1 MIN
Hims & Hers Health Soars on JPMorgan's Bullish Rating
from The Daily News Now! Business
Hims and Hers Health stock surges after JPMorgans bullish rating, with a 35 dollar price target, highlighting their weight-loss partnership with Novo Nordisk and potential for growth, despite recent market volatility. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/eb2c8253189c416a
NOW PLAYING
Hims & Hers Health Soars on JPMorgan's Bullish Rating
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m